Query psy11293
Match_columns 111
No_of_seqs 119 out of 1097
Neff 6.3
Searched_HMMs 46136
Date Fri Aug 16 23:11:24 2013
Command hhsearch -i /work/01045/syshi/Psyhhblits/psy11293.a3m -d /work/01045/syshi/HHdatabase/Cdd.hhm -o /work/01045/syshi/hhsearch_cdd/11293hhsearch_cdd -cpu 12 -v 0
No Hit Prob E-value P-value Score SS Cols Query HMM Template HMM
1 cd01328 FSL_SPARC Follistatin- 99.9 4.9E-22 1.1E-26 131.1 7.0 74 30-106 1-85 (86)
2 smart00280 KAZAL Kazal type se 99.6 2.4E-16 5.1E-21 92.1 4.4 45 55-104 2-46 (46)
3 cd01327 KAZAL_PSTI Kazal-type 99.6 8.3E-16 1.8E-20 90.1 4.5 43 57-104 3-45 (45)
4 PF07648 Kazal_2: Kazal-type s 99.4 6.5E-14 1.4E-18 79.5 3.0 36 69-104 7-42 (42)
5 KOG4004|consensus 99.4 8.8E-14 1.9E-18 104.6 3.3 81 27-109 49-138 (259)
6 cd00104 KAZAL_FS Kazal type se 99.4 2.5E-13 5.5E-18 77.1 3.8 36 69-104 6-41 (41)
7 PF00050 Kazal_1: Kazal-type s 99.4 2.2E-13 4.8E-18 80.6 3.5 41 59-104 8-48 (48)
8 KOG3555|consensus 98.8 9.2E-10 2E-14 88.4 1.5 75 26-105 85-184 (434)
9 KOG4578|consensus 98.6 7.9E-09 1.7E-13 82.8 1.1 49 55-109 34-82 (421)
10 smart00057 FIMAC factor I memb 98.6 8.8E-08 1.9E-12 60.9 4.6 65 30-106 1-69 (69)
11 cd01330 KAZAL_SLC21 The kazal- 97.5 5.8E-05 1.3E-09 45.8 1.9 19 68-86 16-34 (54)
12 smart00274 FOLN Follistatin-N- 96.8 0.001 2.3E-08 34.6 2.2 24 30-54 1-24 (26)
13 PF09289 FOLN: Follistatin/Ost 96.3 0.0021 4.5E-08 32.3 1.0 22 31-53 1-22 (22)
14 TIGR00805 oat sodium-independe 93.0 0.069 1.5E-06 45.7 2.3 18 68-85 460-477 (633)
15 KOG4597|consensus 92.1 0.17 3.7E-06 42.9 3.6 64 29-100 104-168 (560)
16 KOG3626|consensus 87.8 0.34 7.4E-06 42.9 2.0 18 68-85 525-542 (735)
17 KOG3509|consensus 86.4 1 2.2E-05 41.1 4.2 76 28-108 172-264 (964)
18 PF00008 EGF: EGF-like domain 75.6 2.1 4.5E-05 22.6 1.5 26 31-57 1-26 (32)
19 KOG4289|consensus 56.8 8.8 0.00019 37.3 2.4 74 31-108 1719-1809(2531)
20 cd00053 EGF Epidermal growth f 50.5 25 0.00054 17.2 2.7 22 33-56 5-26 (36)
21 smart00179 EGF_CA Calcium-bind 44.5 33 0.00071 17.5 2.6 25 30-56 4-29 (39)
22 smart00181 EGF Epidermal growt 42.9 37 0.00079 17.1 2.6 24 31-57 2-26 (35)
23 KOG1219|consensus 41.2 35 0.00076 35.2 3.8 26 29-56 3904-3929(4289)
24 KOG1219|consensus 35.0 30 0.00065 35.7 2.3 29 28-57 3864-3892(4289)
25 cd00054 EGF_CA Calcium-binding 34.0 59 0.0013 16.0 2.6 25 30-56 4-29 (38)
26 PF12946 EGF_MSP1_1: MSP1 EGF 28.4 29 0.00062 19.4 0.7 25 31-56 2-26 (37)
27 COG2830 Uncharacterized protei 26.0 35 0.00076 25.7 1.0 16 1-16 1-16 (214)
28 PF01422 zf-NF-X1: NF-X1 type 25.5 33 0.00072 16.6 0.5 11 98-108 9-19 (20)
29 PF07645 EGF_CA: Calcium-bindi 23.6 61 0.0013 17.6 1.5 21 35-57 11-31 (42)
No 1
>cd01328 FSL_SPARC Follistatin-like SPARC (secreted protein, acidic, and rich in cysteines) domain; SPARC/BM-40/osteonectin is a multifunctional glycoprotein which modulates cellular interaction with the extracellular matrix by its binding to structural matrix proteins such as collagen and vitronectin. The protein it composed of an N-terminal acidic region, a follistatin (FS) domain and an EF-hand calcium binding domain. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a small hydrophobic core of alpha/beta structure (Kazal domain) and has five disulfide bonds and a conserved N-glycosylation site. The FSL_SPARC domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=99.86 E-value=4.9e-22 Score=131.15 Aligned_cols=74 Identities=31% Similarity=0.813 Sum_probs=64.9
Q ss_pred CCCCccCCCCCeeccCCCCCcceeecCCCCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCC-----------CceeE
Q psy11293 30 PCQENTCQYGAKCIPSEDGTSYKCECPQECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTK-----------TNLTI 98 (111)
Q Consensus 30 ~C~~~~C~~G~~C~~~~~g~~~~CvC~~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~-----------~~i~v 98 (111)
||+++.|++|.+|+++..+ .|+|+|+..||... .+..+||||||+||+|+|+|++++|..+ ..|+|
T Consensus 1 pC~~v~C~~G~~C~~d~~~-~p~CvC~~~Cp~~~--~~~~~VCGsDg~TY~s~C~L~r~~C~~~~~~~~~~~~~~~~l~i 77 (86)
T cd01328 1 PCENHHCGAGKVCEVDDEN-TPKCVCIDPCPEEV--DDRRKVCTNDNETFDSDCELYRTRCLCKGGKKGCRGPKYQHLHL 77 (86)
T ss_pred CCCCcCCCCCCEeeECCCC-CeEEecCCcCCCCC--CCCCceeCCCCCCcccHhHHhhhHhccCCCCcCCCCCccCeEEE
Confidence 7999999999999997544 69999999999976 2357899999999999999999999731 48999
Q ss_pred eeeccCCC
Q psy11293 99 KYYGKCGK 106 (111)
Q Consensus 99 ~~~G~C~~ 106 (111)
.|+|+|..
T Consensus 78 ~Y~G~Ck~ 85 (86)
T cd01328 78 DYYGECKE 85 (86)
T ss_pred EeeccccC
Confidence 99999973
No 2
>smart00280 KAZAL Kazal type serine protease inhibitors. Kazal type serine protease inhibitors and follistatin-like domains.
Probab=99.64 E-value=2.4e-16 Score=92.15 Aligned_cols=45 Identities=40% Similarity=1.009 Sum_probs=42.1
Q ss_pred cCCCCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCCCceeEeeeccC
Q psy11293 55 CPQECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKC 104 (111)
Q Consensus 55 C~~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C 104 (111)
|+..|+..+ .|||||||+||.|+|+|+.++|..+..|.++|+|+|
T Consensus 2 C~~~C~~~~-----~pVCgsdg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 46 (46)
T smart00280 2 CPEACPREY-----DPVCGSDGVTYSNECHLCKAACESGKSIEVKHDGPC 46 (46)
T ss_pred CCCCCCCCC-----CccCCCCCCEeCCHhHHHHHHhcCCCCeEEeecCCC
Confidence 777899876 899999999999999999999999999999999987
No 3
>cd01327 KAZAL_PSTI Kazal-type pancreatic secretory trypsin inhibitors (PSTI) and related proteins, including the second domain of the ovomucoid turkey inhibitor and the C-terminal domain of the esophagus cancer-related gene-2 protein (ECRG-2), are members of the superfamily of kazal-type proteinase inhibitors and follistatin-like proteins.
Probab=99.61 E-value=8.3e-16 Score=90.14 Aligned_cols=43 Identities=37% Similarity=0.763 Sum_probs=39.7
Q ss_pred CCCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCCCceeEeeeccC
Q psy11293 57 QECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKC 104 (111)
Q Consensus 57 ~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C 104 (111)
..||..+ .|||||||+||.|+|+|+.++|..+..|.++|.|+|
T Consensus 3 ~~Cp~~~-----~PVCGsDg~TY~N~C~l~~~~c~~~~~i~~~~~G~C 45 (45)
T cd01327 3 FGCPKDY-----DPVCGTDGVTYSNECLLCAENLKRQTNIRIKHDGEC 45 (45)
T ss_pred CCCCCCC-----CceeCCCCCEeCCHhHHHHHHhccCCCeEEeecCCC
Confidence 4677776 899999999999999999999999999999999987
No 4
>PF07648 Kazal_2: Kazal-type serine protease inhibitor domain; InterPro: IPR011497 This domain is usually indicative of serine protease inhibitors that belong to Merops inhibitor families: I1, I2, I17 and I31. However, kazal-like domains are also seen in the extracellular part of agrins, which are not known to be protease inhibitors. Kazal domains often occur in tandem arrays and have a central alpha-helix, a short two-stranded antiparallel beta-sheet and several disulphide bonds [, , ]. The amino terminal segment of this domain binds to the active site of its target proteases, thus inhibiting their function.; PDB: 2KMP_A 1LDT_L 2KMR_A 2KMO_A 2KMQ_A 1AN1_I 4E0S_B 3T5O_A 4A5W_B 1LR7_A ....
Probab=99.44 E-value=6.5e-14 Score=79.49 Aligned_cols=36 Identities=42% Similarity=0.929 Sum_probs=34.6
Q ss_pred CCeecCCCceeCCccHHHHHHhcCCCceeEeeeccC
Q psy11293 69 RPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKC 104 (111)
Q Consensus 69 ~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C 104 (111)
.||||+||+||.|+|+|++++|..+..+.+++.|+|
T Consensus 7 ~PVCg~dg~ty~n~C~l~~~~c~~~~~~~~~~~g~C 42 (42)
T PF07648_consen 7 SPVCGSDGKTYSNECELRCANCRTNSKIQIVHDGSC 42 (42)
T ss_dssp STEEETTSEEESSHHHHHHHHHHHTTTCEEEEESSS
T ss_pred CCEEcCCCCEEhhHHHHHHHHHhcCCCeEEEeCCCC
Confidence 399999999999999999999999999999999987
No 5
>KOG4004|consensus
Probab=99.42 E-value=8.8e-14 Score=104.63 Aligned_cols=81 Identities=28% Similarity=0.740 Sum_probs=69.9
Q ss_pred CCCCCCCccCCCCCeeccCCCCCcceeecCC-CCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcC-----CCceeEee
Q psy11293 27 LTNPCQENTCQYGAKCIPSEDGTSYKCECPQ-ECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCST-----KTNLTIKY 100 (111)
Q Consensus 27 ~~~~C~~~~C~~G~~C~~~~~g~~~~CvC~~-~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~-----~~~i~v~~ 100 (111)
.++||++.+|++|..|+++..+ +|+|+|.. .||... ..+.+.|||.||+||.|.|+|++.+|.. ...+++.|
T Consensus 49 a~npC~dh~Cg~gk~C~vd~~~-~P~Cvc~~~kCP~~~-~~p~~KVC~nnNqTf~S~C~~~~~~C~~~~~~k~~k~hl~y 126 (259)
T KOG4004|consen 49 ARNPCADHKCGPGKNCLVDLQT-QPRCVCCRYKCPRKQ-QRPVHKVCGNNNQTFNSWCEMHKHSCESRYFIKVHKLHLKY 126 (259)
T ss_pred ccCccccccCCCCceeeecCCC-CceeEEecCCCCccc-CCchhhhhcCCCcchhHHHHHHHhhhhhhcccccceeehhc
Confidence 5899999999999999998776 69999876 999854 2466789999999999999999999985 34677799
Q ss_pred eccCC---CCcc
Q psy11293 101 YGKCG---KWIL 109 (111)
Q Consensus 101 ~G~C~---~c~~ 109 (111)
.|+|+ +|++
T Consensus 127 ~G~Ck~i~~c~d 138 (259)
T KOG4004|consen 127 QGSCKYIPPCLD 138 (259)
T ss_pred ccccccCCchhH
Confidence 99997 6765
No 6
>cd00104 KAZAL_FS Kazal type serine protease inhibitors and follistatin-like domains. Kazal inhibitors inhibit serine proteases, such as, trypsin, chyomotrypsin, avian ovomucoids, and elastases. The inhibitory domain has one reactive site peptide bond, which serves the cognate enzyme as substrate. The reactive site peptide bond is a combining loop which has an identical conformation in all Kazal inhibitors and in all enzyme/inhibitor complexes. These Kazal domains (small hydrophobic core of alpha/beta structure with 3 to 4 disulfide bonds) often occur in tandem arrays. Similar domains are also present in follistatin (FS) and follistatin-like family members, which play an important role in tissue specific regulation. The FS domain consists of an N-terminal beta hairpin (FOLN/EGF-like domain) and a Kazal-like domain and has five disulfide bonds. Although the Kazal-like FS substructure is similar to Kazal proteinase inhibitors, no FS domain has yet been shown to be a proteinase inhibitor.
Probab=99.41 E-value=2.5e-13 Score=77.14 Aligned_cols=36 Identities=36% Similarity=0.869 Sum_probs=34.6
Q ss_pred CCeecCCCceeCCccHHHHHHhcCCCceeEeeeccC
Q psy11293 69 RPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKC 104 (111)
Q Consensus 69 ~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C 104 (111)
.||||+||+||.|+|+|+.++|..+..|.+.+.|+|
T Consensus 6 ~pVCgsdg~tY~n~C~~~~~~c~~~~~~~~~~~g~C 41 (41)
T cd00104 6 DPVCGSDGKTYSNECHLGCAACRSGRSITVAHNGPC 41 (41)
T ss_pred CccCCCCCCEECCHhhhhHHhhcCCCCeEEEeccCC
Confidence 899999999999999999999998899999999987
No 7
>PF00050 Kazal_1: Kazal-type serine protease inhibitor domain; InterPro: IPR002350 Peptide proteinase inhibitors can be found as single domain proteins or as single or multiple domains within proteins; these are referred to as either simple or compound inhibitors, respectively. In many cases they are synthesised as part of a larger precursor protein, either as a prepropeptide or as an N-terminal domain associated with an inactive peptidase or zymogen. This domain prevents access of the substrate to the active site. Removal of the N-terminal inhibitor domain either by interaction with a second peptidase or by autocatalytic cleavage activates the zymogen. Other inhibitors interact direct with proteinases using a simple noncovalent lock and key mechanism; while yet others use a conformational change-based trapping mechanism that depends on their structural and thermodynamic properties. This family of Kazal inhibitors, belongs to MEROPS inhibitor family I1, clan IA. They inhibit serine peptidases of the S1 family (IPR001254 from INTERPRO) []. The members are primarily metazoan, but includes exceptions in the alveolata (apicomplexa), stramenopiles, higher plants and bacteria. Kazal inhibitors, which inhibit a number of serine proteases (such as trypsin and elastase), belong to family of proteins that includes pancreatic secretory trypsin inhibitor; avian ovomucoid; acrosin inhibitor; and elastase inhibitor. These proteins contain between 1 and 7 Kazal-type inhibitor repeats [, ]. The structure of the Kazal repeat includes a large quantity of extended chain, 2 short alpha-helices and a 3-stranded anti-parallel beta sheet [].The inhibitor makes 11 contacts with its enzyme substrate: unusually, 8 of these important residues are hypervariable []. Altering the enzyme-contact residues, and especially that of the active site bond, affects the the strength of inhibition and specificity of the inhibitor for particular serine proteases [, ]. The presence of this Pfam domain is usually indicative of serine protease inhibitors, however, Kazal-like domains are also seen in the extracellular part of agrins which are not known to be proteinase inhibitors.; GO: 0005515 protein binding; PDB: 1HPT_A 1CGI_I 1CGJ_I 2P6A_D 3HH2_C 2B0U_D 2BUS_A 1BUS_A 1OVO_A 3OVO_A ....
Probab=99.40 E-value=2.2e-13 Score=80.61 Aligned_cols=41 Identities=41% Similarity=0.822 Sum_probs=32.6
Q ss_pred CCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCCCceeEeeeccC
Q psy11293 59 CPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKC 104 (111)
Q Consensus 59 C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C 104 (111)
|+..+ .|||||||+||+|+|+|..+.-..+..|.++|.|+|
T Consensus 8 C~~~~-----~PVCGsdg~TY~N~C~lC~~~~~~~~~i~~~~~G~C 48 (48)
T PF00050_consen 8 CPREY-----DPVCGSDGVTYSNECELCAANRRSGKNIRIAHDGPC 48 (48)
T ss_dssp EESSC-----S-EEETTSEEESSHHHHHHHHHHTTTSS-EEEESS-
T ss_pred CCCCC-----CceECCCCCCccccchhhhhhcccCCCeEEeecCCC
Confidence 66554 899999999999999996555577899999999987
No 8
>KOG3555|consensus
Probab=98.84 E-value=9.2e-10 Score=88.45 Aligned_cols=75 Identities=25% Similarity=0.633 Sum_probs=61.6
Q ss_pred CCCCCCCCccCCCCCeeccCCCCCcceeecC-------------------------CCCCCCCCCCCCCCeecCCCceeC
Q psy11293 26 ELTNPCQENTCQYGAKCIPSEDGTSYKCECP-------------------------QECPNYGDHTGSRPVCGSNGVDYK 80 (111)
Q Consensus 26 ~~~~~C~~~~C~~G~~C~~~~~g~~~~CvC~-------------------------~~C~~~~~~~~~~pVCGsDG~TY~ 80 (111)
...+||..++|.+.++|+.. +.+++.|+-. .+||... ..+||||||+||+
T Consensus 85 ~~kdpc~kvkcs~hkvci~Q-d~Q~A~cis~k~l~~r~k~a~v~~~q~~d~~l~~CKpCpvaq----~a~vCGsDghtYs 159 (434)
T KOG3555|consen 85 PIKDPCLKVKCSRHKVCIAQ-DYQTAGCISRKQLQHRQKAAGVSVIQWDDPELDNCKPCPVAQ----PAFVCGSDGHTYS 159 (434)
T ss_pred cccChHhhhcccccceeecc-ccchhhhHHHHHHhhhccCCCcceecccCcccccCccCCccc----ccceecCCCCeeh
Confidence 45799999999999999884 4444444311 1577665 4789999999999
Q ss_pred CccHHHHHHhcCCCceeEeeeccCC
Q psy11293 81 DLCEFQRASCSTKTNLTIKYYGKCG 105 (111)
Q Consensus 81 n~C~L~~~aC~~~~~i~v~~~G~C~ 105 (111)
+.|.|..++|....+|.|...|+|.
T Consensus 160 s~ckLe~~aC~~sksiav~c~g~cp 184 (434)
T KOG3555|consen 160 SRCKLEYHACHVSKSIAVICEGPCP 184 (434)
T ss_pred hhhhHHHHhhhhhhhhhhhhCCCCC
Confidence 9999999999999999999999985
No 9
>KOG4578|consensus
Probab=98.64 E-value=7.9e-09 Score=82.76 Aligned_cols=49 Identities=41% Similarity=0.933 Sum_probs=43.7
Q ss_pred cCCCCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCCCceeEeeeccCCCCcc
Q psy11293 55 CPQECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTKTNLTIKYYGKCGKWIL 109 (111)
Q Consensus 55 C~~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~~G~C~~c~~ 109 (111)
|...|.... .|||||||+||++.|+|.++.|.. ..|.++|.|.|..|..
T Consensus 34 c~l~C~~~~-----kPvCasDGrty~srCe~qRAkC~d-pql~~~yrG~Ck~C~~ 82 (421)
T KOG4578|consen 34 CQLECDDNE-----KPVCASDGRTYPSRCELQRAKCGD-PQLSLKYRGSCKACLE 82 (421)
T ss_pred hccccCCCC-----CCccccCCccchhHHHHHHhhcCC-CceeEEecCcHHHHHH
Confidence 666777765 899999999999999999999995 8999999999998864
No 10
>smart00057 FIMAC factor I membrane attack complex.
Probab=98.59 E-value=8.8e-08 Score=60.86 Aligned_cols=65 Identities=29% Similarity=0.662 Sum_probs=55.6
Q ss_pred CCCCccCCCCCeeccCCCCCcceeec--CCCCCCCCCCCCCCCeecCCCcee--CCccHHHHHHhcCCCceeEeeeccCC
Q psy11293 30 PCQENTCQYGAKCIPSEDGTSYKCEC--PQECPNYGDHTGSRPVCGSNGVDY--KDLCEFQRASCSTKTNLTIKYYGKCG 105 (111)
Q Consensus 30 ~C~~~~C~~G~~C~~~~~g~~~~CvC--~~~C~~~~~~~~~~pVCGsDG~TY--~n~C~L~~~aC~~~~~i~v~~~G~C~ 105 (111)
+|+.+.|.+|..|.. .+|+| |.+||... ..||..|++.| .|+|+|...+|.. ..+++.+.|+|.
T Consensus 1 sc~c~~C~pWekc~~------~~CvCk~P~qC~~~~-----~~vCv~~~~~~~t~S~C~~~a~~C~g-~~~~~~~~g~C~ 68 (69)
T smart00057 1 SCAKVFCQPWQKCSA------STCVCKLPYECPKAG-----TDVCVEDGRSEKTLTYCKQKSLECLN-PKYKFLHIGSCT 68 (69)
T ss_pred CCcCccCCCcccccC------CeeEeCCHhHCCCCC-----CCeeEecCceeeeecHHHHHHHHhcC-CCcEEeccCCCC
Confidence 366779999999986 46888 46899864 58999999999 9999999999995 899999999886
Q ss_pred C
Q psy11293 106 K 106 (111)
Q Consensus 106 ~ 106 (111)
.
T Consensus 69 ~ 69 (69)
T smart00057 69 A 69 (69)
T ss_pred C
Confidence 3
No 11
>cd01330 KAZAL_SLC21 The kazal-type serine protease inhibitor domain has been detected in an extracellular loop region of solute carrier 21 (SLC21) family members (organic anion transporters) , which may regulate the specificity of anion uptake. The KAZAL_SLC21 domain is a member of the superfamily of kazal-like proteinase inhibitors and follistatin-like proteins.
Probab=97.51 E-value=5.8e-05 Score=45.75 Aligned_cols=19 Identities=42% Similarity=0.912 Sum_probs=17.2
Q ss_pred CCCeecCCCceeCCccHHH
Q psy11293 68 SRPVCGSNGVDYKDLCEFQ 86 (111)
Q Consensus 68 ~~pVCGsDG~TY~n~C~L~ 86 (111)
+.||||+||+||.|.|++-
T Consensus 16 ~~PVCg~~g~tY~SpC~AG 34 (54)
T cd01330 16 YSPVCGENGITYFSPCHAG 34 (54)
T ss_pred cCCccCCCCCEEcCHhHcC
Confidence 4799999999999999874
No 12
>smart00274 FOLN Follistatin-N-terminal domain-like. Follistatin-N-terminal domain-like, EGF-like. Region distinct from the kazal-like sequence
Probab=96.83 E-value=0.001 Score=34.60 Aligned_cols=24 Identities=25% Similarity=0.888 Sum_probs=20.2
Q ss_pred CCCCccCCCCCeeccCCCCCcceee
Q psy11293 30 PCQENTCQYGAKCIPSEDGTSYKCE 54 (111)
Q Consensus 30 ~C~~~~C~~G~~C~~~~~g~~~~Cv 54 (111)
+|+++.|++|++|+.+. .+.|+|+
T Consensus 1 ~C~~v~C~~G~~C~~d~-~g~p~Cv 24 (26)
T smart00274 1 SCRNVQCPFGKVCVVDK-GGNARCV 24 (26)
T ss_pred CCCCEECCCCCEEEeCC-CCCEEEe
Confidence 69999999999999974 4458885
No 13
>PF09289 FOLN: Follistatin/Osteonectin-like EGF domain; InterPro: IPR015369 This domain is predominantly found in osteonectin and follistatin. They adopt an EGF-like structure [, ]. Follistatin is involved in diverse activities from embryonic development to cell secretion. ; GO: 0005515 protein binding; PDB: 1LR7_A 1LR8_A 1LR9_A 2ARP_F 3B4V_H 2KCX_A 3SEK_C 2P6A_D 3HH2_C 2B0U_D ....
Probab=96.27 E-value=0.0021 Score=32.30 Aligned_cols=22 Identities=32% Similarity=0.816 Sum_probs=15.7
Q ss_pred CCCccCCCCCeeccCCCCCccee
Q psy11293 31 CQENTCQYGAKCIPSEDGTSYKC 53 (111)
Q Consensus 31 C~~~~C~~G~~C~~~~~g~~~~C 53 (111)
|+++.|++|++|.++.+++ |+|
T Consensus 1 C~n~~Ck~GKvC~~d~~~~-P~C 22 (22)
T PF09289_consen 1 CDNFHCKRGKVCKVDEQGK-PHC 22 (22)
T ss_dssp STT---BTTEEEEEETTTC-EEE
T ss_pred CCCcccCCCCEeeeCCCCC-cCC
Confidence 7899999999999987664 766
No 14
>TIGR00805 oat sodium-independent organic anion transporter. Proteins of the OAT family catalyze the Na+-independent facilitated transport of organic anions such as bromosulfobromophthalein and prostaglandins as well as conjugated and unconjugated bile acids (taurocholate and cholate, respectively). These transporters have been characterized in mammals, but homologues are present in C. elegans and A. thaliana. Some of the mammalian proteins exhibit a high degree of tissue specificity. For example, the rat OAT is found at high levels in liver and kidney and at lower levels in other tissues. These proteins possess 10-12 putative a-helical transmembrane spanners. They may catalyze electrogenic anion uniport or anion exchange.
Probab=92.96 E-value=0.069 Score=45.73 Aligned_cols=18 Identities=44% Similarity=0.960 Sum_probs=16.7
Q ss_pred CCCeecCCCceeCCccHH
Q psy11293 68 SRPVCGSNGVDYKDLCEF 85 (111)
Q Consensus 68 ~~pVCGsDG~TY~n~C~L 85 (111)
+.||||.||.||=|.|+-
T Consensus 460 ~~PVCg~~~~tY~SpC~A 477 (633)
T TIGR00805 460 FDPVCGDNGLAYLSPCHA 477 (633)
T ss_pred cccccCCCCCEEECcccc
Confidence 589999999999999985
No 15
>KOG4597|consensus
Probab=92.13 E-value=0.17 Score=42.86 Aligned_cols=64 Identities=27% Similarity=0.679 Sum_probs=52.1
Q ss_pred CCCCCccCC-CCCeeccCCCCCcceeecCCCCCCCCCCCCCCCeecCCCceeCCccHHHHHHhcCCCceeEee
Q psy11293 29 NPCQENTCQ-YGAKCIPSEDGTSYKCECPQECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASCSTKTNLTIKY 100 (111)
Q Consensus 29 ~~C~~~~C~-~G~~C~~~~~g~~~~CvC~~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC~~~~~i~v~~ 100 (111)
..|+...|. .|.+|..- ++ +++|.|...|.... .--|.+||-+|-| |.|...+|..+..++|.+
T Consensus 104 a~~~~~~~~qq~s~~dif-~~-~~r~~~~~~~~~eP-----~~~~~d~~~k~~n-~t~cs~aCgKG~q~~iv~ 168 (560)
T KOG4597|consen 104 ALCAQFPCSQQGSVCDIF-DG-QPRCTCIDRCEKEP-----SFTCADDGLKYYN-CTMCSEACGKGVQLRIVY 168 (560)
T ss_pred chhccCcccccccccccc-CC-CCCcccccccccCC-----chhhhhcCceecc-eEehhhhhcCCceeeeEE
Confidence 557777776 56677773 44 48999998888876 6689999999999 999999999988888765
No 16
>KOG3626|consensus
Probab=87.80 E-value=0.34 Score=42.89 Aligned_cols=18 Identities=44% Similarity=0.992 Sum_probs=16.6
Q ss_pred CCCeecCCCceeCCccHH
Q psy11293 68 SRPVCGSNGVDYKDLCEF 85 (111)
Q Consensus 68 ~~pVCGsDG~TY~n~C~L 85 (111)
..||||.||.||-|.|+-
T Consensus 525 ~~PVCg~~G~tY~SpChA 542 (735)
T KOG3626|consen 525 YEPVCGENGITYFSPCHA 542 (735)
T ss_pred cCcccCCCCCEEeChhhh
Confidence 589999999999999985
No 17
>KOG3509|consensus
Probab=86.44 E-value=1 Score=41.09 Aligned_cols=76 Identities=20% Similarity=0.210 Sum_probs=57.5
Q ss_pred CCCCCCccCCCCCeeccCCCC-----------------CcceeecCCCCCCCCCCCCCCCeecCCCceeCCccHHHHHHh
Q psy11293 28 TNPCQENTCQYGAKCIPSEDG-----------------TSYKCECPQECPNYGDHTGSRPVCGSNGVDYKDLCEFQRASC 90 (111)
Q Consensus 28 ~~~C~~~~C~~G~~C~~~~~g-----------------~~~~CvC~~~C~~~~~~~~~~pVCGsDG~TY~n~C~L~~~aC 90 (111)
.-+|....|.+|+.|.....- ..++|.|++.+.... .++|..+|+++..++.++.+++
T Consensus 172 ~~~~~~~~~q~g~tC~~~~~~~~~~~~~~~~~~~~c~~~~~r~~~~f~~~~~g-----~~~~~~~~vp~~~e~S~~~~~~ 246 (964)
T KOG3509|consen 172 PIHCAQPVCQGGATCEVRNGKGYSLECPDCKVRVVCEACKPRAFCPFEKSVEG-----CLKCFCFGVPRPSESSLHAFRA 246 (964)
T ss_pred cccccCcccccceeEEecCCcceeeeccccccceehhhccCceeccccccccc-----ccceeecCCCccccchhhhHhh
Confidence 356888999999999985321 113344444444443 7899999999999999999999
Q ss_pred cCCCceeEeeeccCCCCc
Q psy11293 91 STKTNLTIKYYGKCGKWI 108 (111)
Q Consensus 91 ~~~~~i~v~~~G~C~~c~ 108 (111)
..+..+++...+.+..+.
T Consensus 247 ~h~~~~~~~~~~~~~~~s 264 (964)
T KOG3509|consen 247 IHGATLHVDSLGVFFSDS 264 (964)
T ss_pred hccchhccchheeecccc
Confidence 998999998888877654
No 18
>PF00008 EGF: EGF-like domain This is a sub-family of the Pfam entry This is a sub-family of the Pfam entry; InterPro: IPR006209 A sequence of about thirty to forty amino-acid residues long found in the sequence of epidermal growth factor (EGF) has been shown [, , , , ] to be present, in a more or less conserved form, in a large number of other, mostly animal proteins. The list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied. The functional significance of EGF domains in what appear to be unrelated proteins is not yet clear. However, a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase). The EGF domain includes six cysteine residues which have been shown (in EGF) to be involved in disulphide bonds. The main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet. Subdomains between the conserved cysteines vary in length.; GO: 0005515 protein binding; PDB: 1WHE_A 1CCF_A 1APO_A 1WHF_A 2VJ3_A 1TOZ_A 4D90_B 3CFW_A 1EDM_B 1IXA_A ....
Probab=75.62 E-value=2.1 Score=22.63 Aligned_cols=26 Identities=50% Similarity=1.227 Sum_probs=19.7
Q ss_pred CCCccCCCCCeeccCCCCCcceeecCC
Q psy11293 31 CQENTCQYGAKCIPSEDGTSYKCECPQ 57 (111)
Q Consensus 31 C~~~~C~~G~~C~~~~~g~~~~CvC~~ 57 (111)
|...+|..++.|+... .....|.|+.
T Consensus 1 C~~~~C~n~g~C~~~~-~~~y~C~C~~ 26 (32)
T PF00008_consen 1 CSSNPCQNGGTCIDLP-GGGYTCECPP 26 (32)
T ss_dssp TTTTSSTTTEEEEEES-TSEEEEEEBT
T ss_pred CCCCcCCCCeEEEeCC-CCCEEeECCC
Confidence 4556788899999965 3569999874
No 19
>KOG4289|consensus
Probab=56.78 E-value=8.8 Score=37.31 Aligned_cols=74 Identities=26% Similarity=0.607 Sum_probs=41.8
Q ss_pred CCCccCCCCCeeccCCCCCcceeecCC-------------CCCCCCCCCCCCCeecCC----CceeCCccHHHHHHhcCC
Q psy11293 31 CQENTCQYGAKCIPSEDGTSYKCECPQ-------------ECPNYGDHTGSRPVCGSN----GVDYKDLCEFQRASCSTK 93 (111)
Q Consensus 31 C~~~~C~~G~~C~~~~~g~~~~CvC~~-------------~C~~~~~~~~~~pVCGsD----G~TY~n~C~L~~~aC~~~ 93 (111)
|.=-+|...+.|+..+......|.|+. .||+.|+ ..|+||-= -+-|.-.|--..-.|+-
T Consensus 1719 C~lnpc~~~g~Cv~sp~a~GY~C~C~~g~~G~~Ce~~~dq~CPrGWW---G~P~CgpC~CavsKgfdp~CnKt~G~CqC- 1794 (2531)
T KOG4289|consen 1719 CSLNPCENQGTCVRSPGAHGYTCECPPGYTGPYCELRADQPCPRGWW---GFPTCGPCNCAVSKGFDPDCNKTNGQCQC- 1794 (2531)
T ss_pred hcccccccCceeecCCCCCceeEECCCcccCcchhhhccCCCCCccc---CCCCccCccccccCCCCCCccccCcceee-
Confidence 333445555666664433345666653 6999986 38999832 23477777666666653
Q ss_pred CceeEeeeccCCCCc
Q psy11293 94 TNLTIKYYGKCGKWI 108 (111)
Q Consensus 94 ~~i~v~~~G~C~~c~ 108 (111)
++-+..-.|.|-+|+
T Consensus 1795 Ke~hy~~~~~Cl~Cd 1809 (2531)
T KOG4289|consen 1795 KENHYRPIGSCLPCD 1809 (2531)
T ss_pred ccccccCCCcceeec
Confidence 233333345565553
No 20
>cd00053 EGF Epidermal growth factor domain, found in epidermal growth factor (EGF) presents in a large number of proteins, mostly animal; the list of proteins currently known to contain one or more copies of an EGF-like pattern is large and varied; the functional significance of EGF-like domains in what appear to be unrelated proteins is not yet clear; a common feature is that these repeats are found in the extracellular domain of membrane-bound proteins or in proteins known to be secreted (exception: prostaglandin G/H synthase); the domain includes six cysteine residues which have been shown to be involved in disulfide bonds; the main structure is a two-stranded beta-sheet followed by a loop to a C-terminal short two-stranded sheet; Subdomains between the conserved cysteines vary in length; the region between the 5th and 6th cysteine contains two conserved glycines of which at least one is present in most EGF-like domains; a subset of these bind calcium.
Probab=50.45 E-value=25 Score=17.22 Aligned_cols=22 Identities=41% Similarity=1.159 Sum_probs=15.6
Q ss_pred CccCCCCCeeccCCCCCcceeecC
Q psy11293 33 ENTCQYGAKCIPSEDGTSYKCECP 56 (111)
Q Consensus 33 ~~~C~~G~~C~~~~~g~~~~CvC~ 56 (111)
...|..++.|+... ...+|.|+
T Consensus 5 ~~~C~~~~~C~~~~--~~~~C~C~ 26 (36)
T cd00053 5 SNPCSNGGTCVNTP--GSYRCVCP 26 (36)
T ss_pred CCCCCCCCEEecCC--CCeEeECC
Confidence 45677788998854 34888876
No 21
>smart00179 EGF_CA Calcium-binding EGF-like domain.
Probab=44.54 E-value=33 Score=17.50 Aligned_cols=25 Identities=52% Similarity=1.341 Sum_probs=15.9
Q ss_pred CCCC-ccCCCCCeeccCCCCCcceeecC
Q psy11293 30 PCQE-NTCQYGAKCIPSEDGTSYKCECP 56 (111)
Q Consensus 30 ~C~~-~~C~~G~~C~~~~~g~~~~CvC~ 56 (111)
.|.. ..|..++.|+.. .+ ...|.|+
T Consensus 4 ~C~~~~~C~~~~~C~~~-~g-~~~C~C~ 29 (39)
T smart00179 4 ECASGNPCQNGGTCVNT-VG-SYRCECP 29 (39)
T ss_pred cCcCCCCcCCCCEeECC-CC-CeEeECC
Confidence 4444 456777889864 33 3778776
No 22
>smart00181 EGF Epidermal growth factor-like domain.
Probab=42.89 E-value=37 Score=17.14 Aligned_cols=24 Identities=42% Similarity=1.153 Sum_probs=16.2
Q ss_pred CCC-ccCCCCCeeccCCCCCcceeecCC
Q psy11293 31 CQE-NTCQYGAKCIPSEDGTSYKCECPQ 57 (111)
Q Consensus 31 C~~-~~C~~G~~C~~~~~g~~~~CvC~~ 57 (111)
|.. ..|..+ .|... .+..+|.|+.
T Consensus 2 C~~~~~C~~~-~C~~~--~~~~~C~C~~ 26 (35)
T smart00181 2 CASGGPCSNG-TCINT--PGSYTCSCPP 26 (35)
T ss_pred CCCcCCCCCC-EEECC--CCCeEeECCC
Confidence 444 567778 89875 3358898773
No 23
>KOG1219|consensus
Probab=41.21 E-value=35 Score=35.23 Aligned_cols=26 Identities=42% Similarity=1.163 Sum_probs=12.5
Q ss_pred CCCCCccCCCCCeeccCCCCCcceeecC
Q psy11293 29 NPCQENTCQYGAKCIPSEDGTSYKCECP 56 (111)
Q Consensus 29 ~~C~~~~C~~G~~C~~~~~g~~~~CvC~ 56 (111)
+||...+|..|+.|++. ++...|.|+
T Consensus 3904 epC~snPC~~GgtCip~--~n~f~CnC~ 3929 (4289)
T KOG1219|consen 3904 EPCASNPCLTGGTCIPF--YNGFLCNCP 3929 (4289)
T ss_pred ccccCCCCCCCCEEEec--CCCeeEeCC
Confidence 45555555555555553 223455544
No 24
>KOG1219|consensus
Probab=34.96 E-value=30 Score=35.69 Aligned_cols=29 Identities=52% Similarity=1.319 Sum_probs=25.1
Q ss_pred CCCCCCccCCCCCeeccCCCCCcceeecCC
Q psy11293 28 TNPCQENTCQYGAKCIPSEDGTSYKCECPQ 57 (111)
Q Consensus 28 ~~~C~~~~C~~G~~C~~~~~g~~~~CvC~~ 57 (111)
.++|.+.+|..|+.|...+.|+ .+|.|+.
T Consensus 3864 ~d~C~~npCqhgG~C~~~~~gg-y~CkCps 3892 (4289)
T KOG1219|consen 3864 TDPCNDNPCQHGGTCISQPKGG-YKCKCPS 3892 (4289)
T ss_pred ccccccCcccCCCEecCCCCCc-eEEeCcc
Confidence 3899999999999999986654 8999985
No 25
>cd00054 EGF_CA Calcium-binding EGF-like domain, present in a large number of membrane-bound and extracellular (mostly animal) proteins. Many of these proteins require calcium for their biological function and calcium-binding sites have been found to be located at the N-terminus of particular EGF-like domains; calcium-binding may be crucial for numerous protein-protein interactions. Six conserved core cysteines form three disulfide bridges as in non calcium-binding EGF domains, whose structures are very similar. EGF_CA can be found in tandem repeat arrangements.
Probab=34.00 E-value=59 Score=16.04 Aligned_cols=25 Identities=48% Similarity=1.309 Sum_probs=15.5
Q ss_pred CCCC-ccCCCCCeeccCCCCCcceeecC
Q psy11293 30 PCQE-NTCQYGAKCIPSEDGTSYKCECP 56 (111)
Q Consensus 30 ~C~~-~~C~~G~~C~~~~~g~~~~CvC~ 56 (111)
.|.. ..|..++.|+... + ...|.|+
T Consensus 4 ~C~~~~~C~~~~~C~~~~-~-~~~C~C~ 29 (38)
T cd00054 4 ECASGNPCQNGGTCVNTV-G-SYRCSCP 29 (38)
T ss_pred cCCCCCCcCCCCEeECCC-C-CeEeECC
Confidence 4444 4566778888642 2 3678776
No 26
>PF12946 EGF_MSP1_1: MSP1 EGF domain 1; InterPro: IPR024730 This EGF-like domain is found at the C terminus of the malaria parasite MSP1 protein. MSP1 is the merozoite surface protein 1. This domain is part of the C-terminal fragment that is proteolytically processed from the the rest of the protein and is left attached to the surface of the invading parasite [].; PDB: 1N1I_C 2FLG_A 1CEJ_A 2NPR_A 1B9W_A 1OB1_F.
Probab=28.44 E-value=29 Score=19.37 Aligned_cols=25 Identities=36% Similarity=0.922 Sum_probs=16.4
Q ss_pred CCCccCCCCCeeccCCCCCcceeecC
Q psy11293 31 CQENTCQYGAKCIPSEDGTSYKCECP 56 (111)
Q Consensus 31 C~~~~C~~G~~C~~~~~g~~~~CvC~ 56 (111)
|.+..|+..+.|....|| ...|.|-
T Consensus 2 C~~~~cP~NA~C~~~~dG-~eecrCl 26 (37)
T PF12946_consen 2 CIDTKCPANAGCFRYDDG-SEECRCL 26 (37)
T ss_dssp -SSS---TTEEEEEETTS-EEEEEE-
T ss_pred ccCccCCCCcccEEcCCC-CEEEEee
Confidence 778899999999997666 4788875
No 27
>COG2830 Uncharacterized protein conserved in bacteria [Function unknown]
Probab=26.05 E-value=35 Score=25.66 Aligned_cols=16 Identities=44% Similarity=0.706 Sum_probs=12.2
Q ss_pred Cceeeeeeeeeeccee
Q psy11293 1 MKTSFYCYQIFLILDF 16 (111)
Q Consensus 1 ~~~~~~~~~~~~~~~y 16 (111)
|||.|||+|--..+.|
T Consensus 1 MKt~f~~~qgd~LIvy 16 (214)
T COG2830 1 MKTKFYCKQGDHLIVY 16 (214)
T ss_pred CceeeeecCCCEEEEE
Confidence 9999999986544444
No 28
>PF01422 zf-NF-X1: NF-X1 type zinc finger; InterPro: IPR000967 Zinc finger (Znf) domains are relatively small protein motifs which contain multiple finger-like protrusions that make tandem contacts with their target molecule. Some of these domains bind zinc, but many do not; instead binding other metals such as iron, or no metal at all. For example, some family members form salt bridges to stabilise the finger-like folds. They were first identified as a DNA-binding motif in transcription factor TFIIIA from Xenopus laevis (African clawed frog), however they are now recognised to bind DNA, RNA, protein and/or lipid substrates [, , , , ]. Their binding properties depend on the amino acid sequence of the finger domains and of the linker between fingers, as well as on the higher-order structures and the number of fingers. Znf domains are often found in clusters, where fingers can have different binding specificities. There are many superfamilies of Znf motifs, varying in both sequence and structure. They display considerable versatility in binding modes, even between members of the same class (e.g. some bind DNA, others protein), suggesting that Znf motifs are stable scaffolds that have evolved specialised functions. For example, Znf-containing proteins function in gene transcription, translation, mRNA trafficking, cytoskeleton organisation, epithelial development, cell adhesion, protein folding, chromatin remodelling and zinc sensing, to name but a few []. Zinc-binding motifs are stable structures, and they rarely undergo conformational changes upon binding their target. This entry represents a domain presumed to be a zinc binding domain. The following pattern describes the zinc finger: C-X(1-6)-H-X-C-X3-C(H/C)-X(3-4)-(H/C)-X(1-10)-C where X can be any amino acid, and numbers in brackets indicate the number of residues. The two position can be either His or Cys. This domain is found in the human transcriptional repressor NK-X1, a repressor of HLA-DRA transcription; the Drosophila shuttle craft protein, which plays an essential role during the late stages of embryonic neurogenesis; and a yeast hypothetical protein YNL023C. More information about these proteins can be found at Protein of the Month: Zinc Fingers [].; GO: 0003700 sequence-specific DNA binding transcription factor activity, 0008270 zinc ion binding, 0006355 regulation of transcription, DNA-dependent, 0005634 nucleus
Probab=25.50 E-value=33 Score=16.63 Aligned_cols=11 Identities=18% Similarity=0.195 Sum_probs=7.1
Q ss_pred EeeeccCCCCc
Q psy11293 98 IKYYGKCGKWI 108 (111)
Q Consensus 98 v~~~G~C~~c~ 108 (111)
+=|.|+|.+|.
T Consensus 9 ~CH~G~C~pC~ 19 (20)
T PF01422_consen 9 LCHPGPCPPCP 19 (20)
T ss_pred cccCCcCCCCC
Confidence 34557787774
No 29
>PF07645 EGF_CA: Calcium-binding EGF domain; InterPro: IPR001881 A sequence of about forty amino-acid residues found in epidermal growth factor (EGF) has been shown [, , , , , ] to be present in a large number of membrane-bound and extracellular, mostly animal, proteins. Many of these proteins require calcium for their biological function and a calcium-binding site has been found at the N terminus of some EGF-like domains []. Calcium-binding may be crucial for numerous protein-protein interactions. For human coagulation factor IX it has been shown [] that the calcium-ligands form a pentagonal bipyramid. The first, third and fourth conserved negatively charged or polar residues are side chain ligands. The latter is possibly hydroxylated (see aspartic acid and asparagine hydroxylation site) []. A conserved aromatic residue, as well as the second conserved negative residue, are thought to be involved in stabilising the calcium-binding site. As in non-calcium binding EGF-like domains, there are six conserved cysteines and the structure of both types is very similar as calcium-binding induces only strictly local structural changes []. +------------------+ +---------+ | | | | nxnnC-x(3,14)-C-x(3,7)-CxxbxxxxaxC-x(1,6)-C-x(8,13)-Cx | | +------------------+ 'n': negatively charged or polar residue [DEQN] 'b': possibly beta-hydroxylated residue [DN] 'a': aromatic amino acid 'C': cysteine, involved in disulphide bond 'x': any amino acid. ; GO: 0005509 calcium ion binding; PDB: 2VJ3_A 1TOZ_A 1LMJ_A 1UZQ_A 1UZK_A 1UZJ_B 1UZP_A 1EMO_A 1EMN_A 2RR0_A ....
Probab=23.59 E-value=61 Score=17.63 Aligned_cols=21 Identities=43% Similarity=1.208 Sum_probs=15.2
Q ss_pred cCCCCCeeccCCCCCcceeecCC
Q psy11293 35 TCQYGAKCIPSEDGTSYKCECPQ 57 (111)
Q Consensus 35 ~C~~G~~C~~~~~g~~~~CvC~~ 57 (111)
.|..++.|+-.. | ..+|.|+.
T Consensus 11 ~C~~~~~C~N~~-G-sy~C~C~~ 31 (42)
T PF07645_consen 11 NCPENGTCVNTE-G-SYSCSCPP 31 (42)
T ss_dssp SSSTTSEEEEET-T-EEEEEEST
T ss_pred cCCCCCEEEcCC-C-CEEeeCCC
Confidence 466789999853 3 58899874
Done!